The effect of Lycopene on the expression level of Mir-210, Antioxidant factors and apolipoproteins in patients with ischemic heart failure referring to Isfahan Chamran hospital: A randomized Clinical Trial
Phase 3
- Conditions
- Congestive heart failure.Heart failure
- Registration Number
- IRCT20200914048711N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 48
Inclusion Criteria
Patients with ischemic heart failure
Age: 40 -70 years olds
Ejection Fraction: 20 - 40
Exclusion Criteria
Patients with cancer, nephrotic diseases, diabetes, autoimmune diseases, organ transplantation, immunosuppressive drugs, bronchial diseases, stroke, arrhythmia, late surgery, active viral infection, active internal hemorrage, anemia with Hb<10g/dl
Smoking
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart function. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Echocardiogram.;Lipid profile. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Auto analyzer biochemistry.;Total antioxidant capacity. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Assay kit, Spectrophotometer.;Paraoxonase enzyme activity assay. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Assay kit, Spectrophotometer.;Arylesterase enzyme activity assay. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Assay kit, Spectrophotometer.;LDL separation from plasma. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Ultracentrifuge.;Assessment of LDL oxidation. Timepoint: Before of intervention, 60 days after of intervention. Method of measurement: Cuso4, Spectrophotometer.
- Secondary Outcome Measures
Name Time Method